Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Shenandoah Telecom
SHEN
$685M
| $629K | ﹤0.01% |
36,754
+5,218
| +17% | +$86.6K |
|
|
ATNY
2502
DELISTED
API TECHNOLOGIES CORP. COMMON STOCK
ATNY
| $627K | ﹤0.01% |
249,924
-17,299
| -6% | -$37.2K |
|
|
DRWI
2503
DELISTED
DragonWave Inc
DRWI
| $625K | ﹤0.01% |
47,600
| – | – |
|
|
GIFI
2504
DELISTED
Gulf Island Fabrication
GIFI
| $623K | ﹤0.01% |
+55,748
| New | +$710K |
|
2505
HCI Group
HCI
$2.33B
| $622K | ﹤0.01% |
14,065
-23,378
| -62% | -$1.05M |
|
2506
Cheniere Energy
CQP
$33.2B
| $621K | ﹤0.01% |
20,117
| – | – |
|
|
ICON
2507
DELISTED
Iconix Brand Group, Inc.
ICON
| $621K | ﹤0.01% |
2,489
-3,474
| -58% | -$968K |
|
|
AST
2508
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $617K | ﹤0.01% |
134,102
+78,685
| +142% | +$754K |
|
|
CO
2509
DELISTED
Global Cord Blood Corporation
CO
| $616K | ﹤0.01% |
+100,000
| New | +$614K |
|
2510
Calix
CALX
$2.42B
| $615K | ﹤0.01% |
80,846
-383,493
| -83% | -$3.13M |
|
|
CMCT
2511
Creative Media & Community Trust
CMCT
$12M
| – | – |
0
| – | – |
|
2512
iShares US Energy ETF
IYE
$1.82B
| $613K | ﹤0.01% |
14,455
-21,090
| -59% | -$946K |
|
2513
Becton Dickinson
BDX
$51.8B
| $610K | ﹤0.01% |
4,413
-367,683
| -99% | -$50.8M |
|
2514
Walker & Dunlop
WD
$1.38B
| $610K | ﹤0.01% |
22,828
-120,394
| -84% | -$2.67M |
|
2515
WesBanco
WSBC
$3.88B
| $610K | ﹤0.01% |
17,918
-53,225
| -75% | -$1.73M |
|
2516
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.78B
| $608K | ﹤0.01% |
6,089
-18,538
| -75% | -$1.88M |
|
|
TUBE
2517
DELISTED
TubeMogul, Inc.
TUBE
| $607K | ﹤0.01% |
42,475
+31,977
| +305% | +$492K |
|
|
CVO
2518
DELISTED
Cenevo, Inc.
CVO
| $605K | ﹤0.01% |
35,650
+25,217
| +242% | +$459K |
|
|
TBRA
2519
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $605K | ﹤0.01% |
+35,091
| New | +$513K |
|
2520
Logitech
LOGI
$14.3B
| $603K | ﹤0.01% |
41,120
-103,906
| -72% | -$1.56M |
|
2521
Regional Management Corp
RM
$301M
| $603K | ﹤0.01% |
+33,762
| New | +$564K |
|
|
LUX
2522
DELISTED
Luxottica Group
LUX
| $603K | ﹤0.01% |
9,082
-1,333
| -13% | -$88.3K |
|
|
BSFT
2523
DELISTED
BroadSoft, Inc.
BSFT
| $598K | ﹤0.01% |
17,304
-5,967
| -26% | -$211K |
|
2524
Lee Enterprises
LEE
$184M
| $597K | ﹤0.01% |
17,919
+12,296
| +219% | +$386K |
|
|
MBFI
2525
DELISTED
MB Financial Corp
MBFI
| $597K | ﹤0.01% |
+17,343
| New | +$558K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.